Aims
The implication of circulating haematopoietic CD34
+ progenitors in the vasculature is unclear due to the lack of understanding of their characteristics and plasticity mediated by their cellular microenvironment. We investigated how vascular smooth muscle cells (SMCs) and their interactions with endothelial cells (ECs) affect the behaviour and plasticity of CD34 + CD31 + progenitors and the underlying mechanisms.
Methods and results
Human peripheral blood-derived CD34 + CD31 + cells were directly transplanted into injured arteries in vivo and cocultured with ECs and SMCs in vitro. CD34 + CD31 + progenitors injected into wire-injured mouse arteries differentiate into ECs and macrophages in the neoendothelial layer and neointima, respectively. SMC-co-culture increases CD34 + CD31 + cell mobility and adhesion to and transmigration across ECs. Sorted CD34 + CD31 + progenitors that adhered to ECs co-cultured with SMCs have the capacity to form capillary-like structures in Matrigel and chimeric blood vessels in vivo. Sorted transmigrated progenitors give rise to macrophages with increased pro-angiogenic activity. These differentiations of CD34 + CD31 + progenitors into ECs and macrophages are mediated by b 2 -integrin and Notch-1, respectively. b 2 -Integrin and Notch-1 are activated by their counterligands, intercellular adhesion molecule-1 (ICAM-1) and jagged-1, which are highly expressed in the neoendothelium and neointima in injured arteries. Intra-arterial injection of b 2 -integrin-activated CD34 + CD31 + progenitors into wire-injured mouse arteries inhibits neointima formation.
Conclusion
Our findings indicate that the peripheral vascular niches composed of ECs and SMCs may predispose haematopoietic CD34 + CD31 + progenitors to differentiate into ECs and macrophages through the activations of the ICAM-1/b 2 -integrin and jagged-1/Notch-1 cascades, respectively.
Introduction
Endothelial progenitor cells (EPCs) are derived from haematopoietic sources, reside in adult bone marrow, can be mobilized into the peripheral circulation by cytokines and contribute to neovascularization and angiogenesis. 1 Recent studies identified endothelial colonyforming cells (ECFCs) and endothelial cell (EC) colony-forming units (CFU-ECs) derived from human peripheral blood (HPB); ECFCs were discovered to be true EPCs with robust proliferative potential and vessel-forming activity, and CFU-ECs were discovered to be descendants of haematopoietic stem cells that can differentiate into phagocytic macrophages. 2 Cultured CFU-ECs are angiogenic cells co-expressing myeloid and endothelial markers, whereas ECFCs can directly participate in re-endothelialization to reduce arterial neointimal formation. 3, 4 Yet, it remains unclear how these circulating progenitors develop into different cell types; it is believed that cellular co-operation and networks play critical roles in the behaviour and commitment of circulating progenitor cells.
5
CD34 has been commonly used as a marker for isolating circulating EPCs and further applied to enhance the capture of circulating EPCs to the bioengineered stent. 6 Platelet-endothelial cell adhesion molecule-1 (CD31), which has been documented to be involved in the homing and migration of CD34 + cells towards vascular ECs, serves as an early indicator of endothelial differentiation. 7 HPB CD31 + cells exhibited an intimate spatial association with neovessels, which is consistent with their role in promoting neovascularization. 8 The administration of CD31 + cells 8 + progenitors (purity .96%) were isolated from steady-state HPB using a two-step purification assay with anti-CD34-and anti-CD31-conjugated magnetic microbeads. The cells were plated on a plastic dish overnight to avoid contamination by differentiated cells, including active monocytes and circulating ECs. ECFCs and CFU-ECs were isolated and cultured using standard protocols, as described. 13 The use of all donor blood was approved by the institutional review board at the National Health Research Institutes of Taiwan. Written informed consent was obtained from all participants before entry into the study. The investigation conformed to the principles outlined in the Declaration of Helsinki. The detailed procedures are described in the Supplementary material online.
EC-SMC co-culture models
Human umbilical vein endothelial cells (HUVECs) were isolated from fresh human umbilical cords by collagenase perfusion, and human umbilical artery SMCs were obtained from Clonetics (Palo Alto, CA, USA). ECs (5 × 10 5 cells/cm 2 ) were seeded onto the inner side of a 10-mm-thick polyethylene terephthalate membrane (pre-coated with 30 mg/mL fibronectin) containing 8-mm pores (Falcon transwell inserts; Becton Dickinson, Lincoln Park, NJ, USA). SMCs (2 × 10 5 cells/cm 2 ) were seeded onto the bottom surface (pre-coated with fibronectin) of the outer chamber, which was separated from the membrane with ECs by 1 mm, thus forming the media-separation model of EC-SMC co-culture. Controls had ECs as above, but no SMCs in the system (EC/Ø). Empty controls had no cells in the system (Ø/Ø). In some experiments, SMCs were cultured in a lattice made of polymerized collagen, and ECs were seeded on the top of gel, thus forming the gel-embedding model of co-culture (EC/gel-SMC). Controls had ECs as above, but no SMCs embedded in the gel (EC/gel). Empty controls had no cells in the system (Ø /gel). ECs and SMCs were maintained in the shared culture medium containing 2% FBS for 24 h prior to the experiments. The detailed procedures of the EC -SMC and the EC/gel-SMC co-cultures are described in the Supplementary material online. 
Characterization

Animals
Male apolipoprotein E-deficient (apoE -/ -) mice from Jackson Laboratory (Bar Harbor, Maine) and male CB17/severe combined immunodeficiency (SCID) and BALB/nude mice from Charles River (Biolasco, Taipei, Taiwan) were purchased at the age of 4 weeks. Control littermates and nude mice were fed a normal chow diet, and apoE -/ -and SCID mice were fed an atherogenic diet containing 15% (w/v) cocoa butter and 0.25% (w/v) cholesterol (diet W, Hope Farms, Woerden, The Netherlands) during the study period. For all surgical procedures, the mice (6 -8 weeks old, 20 -30 g weight) were treated with isoflurane to induce analgesia and anaesthetized by ip injection of 50 mg/kg pentobarbital diluted in 0.9% sodium chloride solution. The tail pinch reflex, body temperature, respiration rate and depth, tissue/mucous colour, and capillary refill time were monitored to determine the adequacy of anaesthesia throughout the experiments. At the end of experiment, all mice were euthanized by intoxication with 100% carbon dioxide. All experiments were performed in accordance with NIH guidelines and with the approval of the Animal Research Committees of National Health Research Institutes.
Femoral artery wire injury model and cell transplantation
The detailed procedures for the trans-luminal mechanical injury of the femoral artery in mice are provided in the Supplementary material online. To examine the localization and differentiation of CD34 + CD31 + progenitors in the denuded femoral artery, mice were given either 10 7 CFDMA-labelled CD34 + CD31 + progenitors in 200 mL of saline (n ¼ 6) or 200 mL of saline as controls (n ¼ 5) by intra-arterial injection after endothelial denudation. For cell transplantation using apoE -/ -mice, the mice were injected ip with immunosuppressive drug cyclosporine A (15 mg/100 g body weight) daily. In some experiments, mice were given either ICAM-1-Fc-stimulated CD34 + CD31 + progenitors or their adherent progeny in EC-SMC co-culture (n ¼ 6) to assess whether these progenitors function in re-endothelialization and neointimal formation after artery injury. The experimental and control arteries were fixed in 4% paraformaldehyde, followed by immunohistochemical and en face examinations. Figure S1A ). The CD34 + CD31 + progenitors were labelled with CMFDA and injected intra-arterially into SCID mice with femoral artery wire injury for 14 days. Human vWF-positive transplanted cells were mainly detected in the luminal neoendothelial layer ( Figure 1A ), whereas human CD68-positive transplanted cells were primarily localized to the neointimal region ( Figure 1B) , where localized SMCs counterimmunostained for mouse smooth muscle-a-actin (SM-a-actin) ( Figure 1C ). We confirmed the compartmental distribution of CD34
+-CD31 + -derived EC and macrophage lineages in the injured arterial wall by quantifying the number of human-vWF-and -CD68-positive transplanted cells in the different cellular compartments ( Figure 1D ).
SMCs in close proximity to ECs increase CD34
1 CD31 1 cell mobility, adhesion to and transmigration across ECs
We next investigated the effect of SMCs on CD34 + CD31 + cell mobility by plating these progenitors over an EC/gel-SMC co-culture (compared with Ø/gel and EC/gel) for 1 h ( Figure 2A ). The migration paths of these progenitors in the x-y plane showed that they exhibit low mobility (1.3 + 0.2 mm/min) in Ø/gel and either are arrested or randomly migrated (7.0 + 1.1 mm/min) in EC/gel ( Figure 2B ; Supplementary material online, Table S1 ). SMC-co-culture increased the migration speed of CD34 + CD31 + progenitors in the x-y plane ( Figure 2B ; Supplementary material online, Table S1 ) and their transmigration depth in the z-axis direction ( Figure 2C and D) compared with the cells in EC/gel and Ø/gel. To investigate whether SMCs affect the adhesion and transmigration of CD34 + CD31 + progenitors, these CMFDA-labelled cells were placed over an EC-SMC co-culture (compared with Ø/Ø and EC/Ø) for 10 days ( Figure 2E ). The number of CD34 + CD31 + progenitors that adhered to ECs co-cultured with SMCs progressively decreased, whereas the number of progenitors that transmigrated across ECs co-cultured with SMCs progressively increased, and both reached plateaus after 5 days of culture ( Figure 2F ). Co-culture of ECs with SMCs increased adhesion and transmigration of CD34 + CD31
+ progenitors, compared with monocultured ECs ( Figure 2G ).
CD34
1 CD31 1 progenitors divide into at least two distinct subpopulations, with differential plasticity towards ECs and macrophages
To characterize the plasticity of CD34 + CD31 + -derived progenitors in the EC -SMC co-culture, these CMFDA-labelled adherent and transmigrated progeny were collected by FACS sorting ( Figure 3A) .
RT-PCR showed that CD34 + CD31 + progenitors that adhered to
ECs co-cultured with SMCs express high levels of KDR, eNOS, and VE-cadherin ( Figure 3A and Supplementary material online, Figure  S2A ), but not CD133, CD68, CD45, CD115, and CD14, similar to those of HUVECs and ECFCs. In contrast, the transmigrated progenitors in EC-SMC co-culture had marked expressions of CD68, CD45, and CD115, but not KDR, eNOS, and VE-cadherin; these results were similar to the results for CFU-ECs. In contrast to the cells that adhered to EC -SMC, the cells adhered to EC/Ø did not express eNOS and expressed only low levels of CD14. Co-immunostaining of the sorted adherent and transmigrated progenitors with anti-vWF and anti-CD68 antibodies demonstrated that vWF is highly expressed in the adherent, but not the transmigrated, progenitors (Supplementary material online, Figure S2B ). Moreover, the sorted adherent progenitors (.30%) were cobblestone-shaped (Supplementary material online, Figure S2C ) and could form secondary cell colonies (Supplementary material online, Figure S2D ), whereas the transmigrated progenitors were spindle-shaped (Supplementary material online, Figure S2C ), with high granularity but no clonogenicity (data not shown). Cell-cycle analysis showed a higher percentage of the adherent progenitors in the synthetic and G 2 /M phases than the transmigrated progenitors (Supplementary material online, Table S2 ). Scratched wound-healing assays showed that the adherent progenitors mainly adhere to the injured ECs at the wound edge (Supplementary material online, Figure S3A ) and can form intercellular adherens junctions with neighbouring ECs (Supplementary material online, Figure S3B ) to enhance neoendothelization of the injured zone (Supplementary material online, Figure S3C ; Supplementary material online, Movie S2 shows the incorporation of the adherent CD34 + CD31 + progenitors into the neoendothelial area). Compared with the transmigrated progenitors, these adherent progenitors can also form a capillary-network structure on Matrigel (Supplementary material online, Figure S4A ). Oil-Red-O staining of lipid vacuoles with oxidized low-density lipoprotein (ox-LDL) uptake (Supplementary material online, Figure S4B ) and immunostaining of acyl-CoA:cholesterol acyltransferase (ACAT) (Supplementary material online, Figure S4C ), an enzyme that synthesizes cholesterol ester in macrophages, showed ox-LDL accumulation and ACAT expression in the transmigrated, but not the adherent, progenitors. These results indicate that the EC -SMC co-culture forms a special cellular environment, where 
Vascular niches direct CD34
+ CD31 + cell fate the adherent and transmigrated CD34 + CD31 + progenitors display distinct cellular phenotypes ( Figure 3B) , that results in differential plasticity towards ECs and macrophages.
3.5 Angiogenic potential of the adherent and transmigrated CD34 1 CD31
progenitors in vivo
We further characterized the in vivo role of the adherent and transmigrated CD34 + CD31 + progenitors in the EC -SMC co-culture using
Matrigel plug implantation and angiogenesis assays. These two groups of CMFDA-labelled progenitors were sorted from EC -SMC co-culture, mixed with Matrigel, and injected s.c. into mice for 12 days ( Figure 3C ). Un-sorted CD34 + CD31 + progenitors were used as controls. Matrigel plugs removed from the mice (Supplementary material online, Figure S5A ) and immunostained with anti-human CD31 and CD68 antibody showed that the implanted adherent, but not transmigrated ( Figure 3C ) and un-sorted (Supplementary material online, Figure S5B ), progenitors were detected in the vessel lumens, and some of the vessels contained red blood cells (RBCs). The Vascular niches direct CD34 + CD31 + cell fate angiogenic effects of these progenitor cells were examined using DIVAA, which uses implanted angioreactors containing conditioned media of different progenitor cells in Matrigel. Analysis of blood capillaries growth into angioreactors excised 28 days after s.c. implantation in nude mice showed that the conditioned media of the transmigrated progenitors have a higher capacity to induce host angiogenesis than that of the adherent and un-sorted progenitors ( Figure 3D ). This result was confirmed by characterizing these explants with angiogentic EC marker GS isolectin-1 (Supplementary material online, Figure  S6A ). RT -PCR demonstrated that angiogenic factors vascular endothelial growth factor (VEGF) and thymidine phosphorylase (TP) are highly expressed in the transmigrated progenitors and CFU-ECs, but not in the adherent progenitors and ECFCs (Supplementary material online, Figure S6B ).
3.6 ICAM-1/b 2 -integrin signalling activation in EC -SMC co-culture promotes CD34 1 CD31 1 cell recruitment and endothelial differentiation
Compared with monocultured ECs, co-culture of ECs with SMCs induced their ICAM-1 mRNA ( Figure 4A ) and protein ( Figure 4B and Supplementary material online, Figure S7 ) expressions. Compared with the uninjured intact arteries, the neoendothelial layer in wire-injured arteries exhibited a higher expression of ICAM-1 (Supplementary material online, Figure S8 ). CD34 + CD31 + progenitors highly expressed b 2 -integrin (Supplementary material online, Figure  S9A ), which was activated on the surfaces of some cells (58.9 + 4.5% of total cells) that were adhered to monocultured ECs ( Figure 4C ). This b 2 -integrin activation on the adherent progenitors was increased (87.8 + Figure S9A ). Higher expression of Notch-signalling effectors Hes1 and Hes5 in the sorted transmigrated progenitors compared with the adherent progenitors indicates that Notch-1 activation is significantly higher in the transmigrated CD34 + CD31 + progenitors than in the adherent progenitors ( Figure 5A ). Pre-treating CD34 + CD31 + cells with a non-transition state g-secretase inhibitor Compound E to inhibit Notch-1 signalling before adding the cells to EC -SMC co-culture inhibited Hes1 and Hes5 expressions in the transmigrated progenitors ( Figure 5A ) and also reduced the percentage of CD68/CD11c-positive cells ( Figure 5B) . Activation of Notch-1 signalling in the CD34 + CD31 + cells after plating on Jag-1-Fc-and Dll-4-Fc-coated surfaces (Supplementary material online, Figure S9C ) significantly increased the percentage of these CD68/CD11c-positive cells ( Figure 5B ) and their CD68 expression ( Figure 5C ). In contrast, the expression of KDR in Jag-1-Fc and Dll-4-Fc-stimulated CD34 + CD31 + progenitors ( Figure 5D ) and the percentage of these KDR/CD31-positive cells ( Figure 5E ) were significantly lower than in the cells treated with control-Fc. In wire-injured femoral arteries, Jag-1 was highly expressed in the neointimal SMC-rich region, but not the neoendothelial layer ( Figure 5F ). In contrast, Dll-4 was not expressed in this neointimal SMC-rich region ( Figure 5G ). Similar to the controls, the expression of Jag-1 and Dll-4 in uninjured vessels was very low. Similar results were also observed in the monocultured and co-cultured SMCs (Supplementary material online, Figure S7 ). These results suggest that neointimal SMCs may highly express Jag-1, which subsequently activates Notch-1 in the transmigrated CD34 + CD31 + progenitors to promote their differentiation into macrophages.
Intra-arterial injection of
progenitors into injured femoral arteries in apoE 2/2 mice inhibits neointima formation
Given our findings that the adherent CD34 + CD31 + progenitors in the EC -SMC co-culture and the ICAM-1-Fc-stimulated CD34 + CD31 + progenitors were able to differentiate into ECs, we investigated whether these b 2 -integrin-activated cells function therapeutically by promoting re-endothelialization and inhibiting neointima formation in the injured arterial wall. The adherent CD34 + CD31 + progenitors sorted from EC -SMC co-culture and the ICAM-1-Fc-stimulated CD34 + CD31 + progenitors were locally injected into apoE 2/2 mice after wire injury of the femoral artery (n ¼ 5 each). Control groups received saline or IgG-Fc-treated cells (n ¼ 5 each). Histological examinations revealed that the injury scores in all groups were low (mean: 0.5-0.7) and similar. Evans-blue ( Figure 6A ) and Oil-Red-O ( Figure 6B ) staining of whole-mounted femoral arteries 5 or 28 days after surgery showed that local transfer of these b 2--integrin-activated CD34 + CD31
+ cells results in increased re-endothelialization ( Figure 6A ) and decreased lesion formation ( Figure 6B ) in injured arteries compared with the control groups. Cross-sectional analysis of the affected arteries 14 days after surgery by Elastica-van Gieson staining ( Figure 6C ) demonstrated that the neointima formation in the injured arterial wall can be inhibited by local injections of these b 2 -integrin-activated progenitors. These results indicate a potential role of b 2 -integrin-activated CD34 + CD31 + progenitors in therapeutic intervention against neointima formation in the injured arterial wall.
Discussion
In this study, we investigated whether EC -SMC interactions modulate the behaviour and commitment of haematopoietic CD34 + CD31
+ progenitors. Recent studies on EPCs have been hampered by the lack of a standard definition or an accepted methodology for their enumeration. 3 Circulating EPCs were previously thought to co-express CD34, KDR, CD31, and/or CD133. 1 However, the progenitors co-expressing these antigens are not EPCs, but instead they are primitive haematopoietic 14 shown to be haematoendothelial cells. 16 To date, however, no markers are unanimously accepted to define EPCs in adult or embryonic development. Our findings suggest that when adequate progenitor cells are introduced into a certain vascular environment (e.g. wire-injured vessels and EC -SMC co-culture), these progenitor cells are able to differentiate into specific cell lineages via complex cell-cell interaction.
Our findings indicate that the adherent progenitors have the capacity to promote re-endothelialization in vitro and form chimeric blood vessels in vivo, whereas the transmigrated progenitors lack such endothelial activity and give rise to functional macrophages with the ability to induce host angiogenesis in vivo. Our immunohistochemical examinations on the injured arteries showed that vWF staining is also present in the neointima, not just in the endothelial layer ( Figure 1A ). This might be expected because the early incorporation of human EPCs that produce vWF will deposit the vWF in the matrix of the neointima where it may stay for months. It is not likely that the transmigrated progenitors could produce vWF, because these progenitors stained negatively for vWF (Supplementary material online, Figure S2B) . Thus, the appearance of transmigrated progenitors positively stained for vWF in our Matrigel plug implantation experiments ( Figure 3C ) may be attributed to their capacity to absorb vWF from neighbouring ECs, which is a characteristics of CFU-ECs. 3 Our results suggest that SMCs may produce paracrine mediator(s) to prime ECs for enhanced recruitment and endothelial differentiation of CD34 + CD31 + progenitors. This notion was supported by our previous studies, 21 showing that SMCs used in this study were of a synthetic phenotype and could release cytokines interleukin (IL)-1b and IL-6 to induce the EC expression of several chemotactic and adhesive proteins that play a role in the trafficking of circulating progenitor cells. 22 In this study, we further demonstrated that SMC induction of EC ICAM-1 can activate b 2 -integrin on the adherent CD34 + CD31 + progenitors, and this signalling axis promotes CD34 + CD31 + cell adhesion, transmigration, and EC-differentiation.
ICAM-1 and b 2 -integrin play similar roles in modulating the adhesion and transmigration of CD34 + CD31 + progenitors, because their neutralizing antibodies exerted similar inhibitory effects on these two processes ( Figure 4E ). ICAM-1-induced b 2 -integrin engagement can activate signalling proteins Syk and Slp-76, which are involved in the haematopoietic cell contribution to vascular development. 23 Further investigations are needed to determine whether Syk and Slp-76 are involved in ICAM-1/b 2 -integrin-induced EC-differentiation of CD34 + CD31 + progenitors.
Our results on Notch-1-mediated macrophage differentiation of CD34 + CD31 + progenitors are in agreement with the previous studies showing that Notch-1 activation induces differentiation of multipotent HPCs into myeloid cell lineages 24 and enhances pro-angiogenic properties of bone marrow-derived vascular precursor cells in vivo. 25 In addition, we demonstrated that Jag-1, but not Dll-4, is highly expressed in the neointimal SMCs in vivo and the synthetic SMCs in vitro, which may negatively regulate EC differentiation of CD34 + CD31 + progenitors and promote their commitment to myeloid lineage. These results are in agreement with the results of Caolo et al., 26 who showed that Notch-1 signalling is highly activated in SMCs in injured arteries and that blocking Notch-1 signalling by soluble Jag-1 inhibits neointima formation in the carotid artery and enhances re-endothelialization. A growing body of evidence has shown the clinical potential of adult vascular progenitor cells, including CD34
+ cells, in the treatment of cardiovascular risks. 6 However, only a small fraction of these progenitors has been identified as true EPCs with potential benefits, whereas others may promote inflammation or hyperplasia by differentiating into macrophages 27 or SMCs. 28 Thus, it is not surprising that circulating EPCs play a double-edged role in inhibiting or promoting neointimal or atherosclerotic lesion progression in the apoE -/ -mice. 29 Recent studies have modified the current protocols to find alternative sources of progenitor cell therapy. For example, injection of a mixture of CFU-ECs and ECFCs into ischaemia-injured mice resulted in synergistic and superior neovascularization compared with any single-cell type transplantation. 30 Our findings that intra-arterial injection of the sorted adherent CD34 + CD31 + progenitors and the ICAM-1-Fc-stimulated CD34 + CD31 + progenitors into wire-injured femoral arteries in the apoE 2/2 mice results in enhanced re-endothelialization and reduced neointima formation indicate the therapeutic potential of b 2 -integrin-activated vascular progenitor cells for EC dysfunction-associated vascular disorders.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
